Haemonetics Gross Margin 2010-2023 | HAE
Current and historical gross margin for Haemonetics (HAE) over the last 10 years. The current gross profit margin for Haemonetics as of December 31, 2023 is %.
| Haemonetics Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2023-12-31 | $1.27B | $0.67B | 52.96% |
| 2023-09-30 | $1.24B | $0.65B | 52.75% |
| 2023-06-30 | $1.22B | $0.64B | 52.59% |
| 2023-03-31 | $1.17B | $0.62B | 52.70% |
| 2022-12-31 | $1.13B | $0.60B | 52.75% |
| 2022-09-30 | $1.08B | $0.58B | 53.09% |
| 2022-06-30 | $1.03B | $0.54B | 52.63% |
| 2022-03-31 | $0.99B | $0.51B | 50.91% |
| 2021-12-31 | $0.95B | $0.45B | 47.38% |
| 2021-09-30 | $0.93B | $0.43B | 46.36% |
| 2021-06-30 | $0.90B | $0.42B | 46.07% |
| 2021-03-31 | $0.87B | $0.40B | 45.75% |
| 2020-12-31 | $0.88B | $0.43B | 48.70% |
| 2020-09-30 | $0.90B | $0.44B | 48.56% |
| 2020-06-30 | $0.95B | $0.46B | 48.52% |
| 2020-03-31 | $0.99B | $0.49B | 49.09% |
| 2019-12-31 | $1.00B | $0.48B | 48.25% |
| 2019-09-30 | $0.99B | $0.47B | 47.11% |
| 2019-06-30 | $0.98B | $0.45B | 46.11% |
| 2019-03-31 | $0.97B | $0.42B | 43.12% |
| 2018-12-31 | $0.95B | $0.41B | 43.07% |
| 2018-09-30 | $0.94B | $0.41B | 43.66% |
| 2018-06-30 | $0.92B | $0.40B | 43.71% |
| 2018-03-31 | $0.90B | $0.41B | 45.58% |
| 2017-12-31 | $0.90B | $0.39B | 43.43% |
| 2017-09-30 | $0.89B | $0.38B | 42.60% |
| 2017-06-30 | $0.89B | $0.38B | 42.73% |
| 2017-03-31 | $0.89B | $0.38B | 42.66% |
| 2016-12-31 | $0.90B | $0.39B | 42.78% |
| 2016-09-30 | $0.91B | $0.39B | 43.43% |
| 2016-06-30 | $0.91B | $0.39B | 43.54% |
| 2016-03-31 | $0.91B | $0.41B | 44.71% |
| 2015-12-31 | $0.89B | $0.43B | 47.65% |
| 2015-09-30 | $0.89B | $0.43B | 48.04% |
| 2015-06-30 | $0.90B | $0.43B | 47.94% |
| 2015-03-31 | $0.91B | $0.43B | 47.69% |
| 2014-12-31 | $0.93B | $0.44B | 47.68% |
| 2014-09-30 | $0.94B | $0.45B | 48.24% |
| 2014-06-30 | $0.94B | $0.46B | 49.10% |
| 2014-03-31 | $0.94B | $0.47B | 49.84% |
| 2013-12-31 | $0.95B | $0.48B | 50.21% |
| 2013-09-30 | $0.95B | $0.47B | 49.00% |
| 2013-06-30 | $0.94B | $0.45B | 48.02% |
| 2013-03-31 | $0.89B | $0.43B | 48.04% |
| 2012-12-31 | $0.83B | $0.40B | 48.31% |
| 2012-09-30 | $0.77B | $0.38B | 49.61% |
| 2012-06-30 | $0.73B | $0.37B | 50.61% |
| 2012-03-31 | $0.73B | $0.37B | 50.82% |
| 2011-12-31 | $0.71B | $0.36B | 51.05% |
| 2011-09-30 | $0.70B | $0.36B | 51.65% |
| 2011-06-30 | $0.69B | $0.36B | 52.26% |
| 2011-03-31 | $0.68B | $0.36B | 52.44% |
| 2010-12-31 | $0.68B | $0.36B | 52.51% |
| 2010-09-30 | $0.66B | $0.35B | 52.26% |
| 2010-06-30 | $0.65B | $0.34B | 51.99% |
| 2010-03-31 | $0.65B | $0.34B | 52.25% |
| 2009-12-31 | $0.63B | $0.33B | 52.71% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $4.379B | $1.169B |
| Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood supply chain, helping better clinical outcomes. It acquired Pall Corporation's blood collection, filtration and processing product lines. It entered into a long-term supply agreement with Pall. The company acquired Hemerus Medical. It operates under 3 segments: Plasma, Blood Center, and Hospital. Plasma includes plasma collection devices and disposables, plasma donor management software, anticoagulant and saline sold to plasma customers. Blood Center includes blood collection and processing devices and disposables for red cells, platelets and whole blood as well as related donor management software. Hospital includes three product lines, namely, Hemostasis Management, Cell Salvage and Transfusion Management. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $185.474B | 24.35 |
| Stryker (SYK) | United States | $128.161B | 31.78 |
| Boston Scientific (BSX) | United States | $106.966B | 34.07 |
| Medtronic (MDT) | Ireland | $106.730B | 15.11 |
| EssilorLuxottica (ESLOY) | France | $99.574B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.648B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.127B | 29.82 |
| ResMed (RMD) | United States | $27.032B | 27.03 |
| Terumo (TRUMY) | Japan | $25.476B | 35.98 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.896B | 16.03 |
| Baxter (BAX) | United States | $20.785B | 15.16 |
| Koninklijke Philips (PHG) | Netherlands | $19.474B | 15.53 |
| Insulet (PODD) | United States | $11.711B | 61.49 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.741B | 0.00 |
| Demant (WILYY) | Denmark | $9.943B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.934B | 23.64 |
| BellRing Brands (BRBR) | United States | $7.285B | 39.17 |
| Lantheus Holdings (LNTH) | United States | $4.470B | 11.54 |
| Perrigo (PRGO) | Ireland | $4.232B | 12.10 |
| GN Store Nord (GNNDY) | Denmark | $3.937B | 25.50 |
| Envista Holdings (NVST) | United States | $3.485B | 13.26 |
| Prestige Consumer Healthcare (PBH) | United States | $3.482B | 16.46 |
| QuidelOrtho (QDEL) | United States | $2.730B | 9.91 |
| Neogen (NEOG) | United States | $2.679B | 25.77 |
| Green Thumb Industries (GTBIF) | United States | $2.630B | 83.33 |
| ICU Medical (ICUI) | United States | $2.357B | 17.58 |
| TG Therapeutics (TGTX) | United States | $2.161B | 699.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.928B | 0.00 |
| Owens & Minor (OMI) | United States | $1.895B | 18.19 |
| Verano Holdings (VRNOF) | United States | $1.790B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $1.780B | 0.00 |
| InMode (INMD) | Israel | $1.458B | 7.55 |
| LeMaitre Vascular (LMAT) | United States | $1.437B | 47.43 |
| National Vision Holdings (EYE) | United States | $1.388B | 43.24 |
| AdaptHealth (AHCO) | United States | $1.300B | 9.78 |
| Warby Parker (WRBY) | United States | $1.287B | 0.00 |
| AtriCure (ATRC) | United States | $1.115B | 0.00 |
| MacroGenics (MGNX) | United States | $0.982B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.899B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.779B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.712B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.693B | 14.98 |
| Evolus (EOLS) | United States | $0.666B | 0.00 |
| Quanterix (QTRX) | United States | $0.613B | 0.00 |
| Jin Medical (ZJYL) | China | $0.547B | 0.00 |
| Valneva SE (VALN) | France | $0.540B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.509B | 11.02 |
| PetIQ (PETQ) | United States | $0.487B | 18.17 |
| TerrAscend (TSNDF) | Canada | $0.478B | 0.00 |
| ZimVie (ZIMV) | United States | $0.430B | 26.35 |
| OraSure Technologies (OSUR) | United States | $0.421B | 6.96 |
| Biote (BTMD) | United States | $0.417B | 3.96 |
| Aurora Cannabis (ACB) | Canada | $0.393B | 0.00 |
| Surmodics (SRDX) | United States | $0.371B | 40.11 |
| Zynex (ZYXI) | United States | $0.361B | 41.59 |
| Viemed Healthcare (VMD) | United States | $0.314B | 31.11 |
| Cerus (CERS) | United States | $0.301B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.280B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.274B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.241B | 14.70 |
| Organigram Holdings (OGI) | Canada | $0.199B | 0.00 |
| Veru (VERU) | United States | $0.193B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.192B | 0.00 |
| Omeros (OMER) | United States | $0.176B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.163B | 0.00 |
| High Tide (HITI) | Canada | $0.160B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.159B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.134B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.130B | 65.20 |
| FitLife Brands (FTLF) | United States | $0.129B | 20.74 |
| InterCure (INCR) | Israel | $0.122B | 20.54 |
| Fonar (FONR) | United States | $0.102B | 8.80 |
| Cellectar Biosciences (CLRB) | United States | $0.099B | 0.00 |
| MariMed (MRMD) | United States | $0.097B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.096B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.088B | 0.00 |
| Brainsway (BWAY) | Israel | $0.084B | 0.00 |
| Safety Shot (SHOT) | United States | $0.081B | 0.00 |
| Chimerix (CMRX) | United States | $0.081B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.060B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.059B | 3.86 |
| Apyx Medical (APYX) | United States | $0.052B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.045B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.044B | 0.00 |
| ImmuCell (ICCC) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.039B | 15.04 |
| Bright Green (BGXX) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.035B | 0.00 |
| Exagen (XGN) | United States | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 0.00 |
| Flora Growth (FLGC) | United States | $0.020B | 0.00 |
| Agape ATP (ATPC) | $0.020B | 0.00 | |
| FSD PHARMA (HUGE) | Canada | $0.018B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.013B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 72.54 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.001B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |